# Crystal L. Mackall

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/crystal-l-mackall-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,010 |
| Field | CAR-T cell therapy research |
| h-index | 73 |
| i10-index | 147 |
| Last Known Institution | Parker Institute for Cancer Immunotherapy |
| OpenAlex ID | https://openalex.org/A5087779758 |
| ORCID iD | https://orcid.org/0000-0003-0359-9023 |
| Works | 511 |

## Researcher papers

- [T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial](https://scholariq.org/papers/t-cells-expressing-cd19-chimeric-antigen-receptors-for-acute-lymphoblastic/)
- [Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1](https://scholariq.org/papers/tumor-regression-in-patients-with-metastatic-synovial-cell-sarcoma-and-melanoma/)
- [CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy](https://scholariq.org/papers/cd22-targeted-car-t-cells-induce-remission-in-b-all-that-is-naive-or-resistant/)
- [CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial](https://scholariq.org/papers/cd4-cd8-t-cell-selection-affects-chimeric-antigen-receptor-car-t-cell-potency/)
- [Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL](https://scholariq.org/papers/long-term-follow-up-of-cd19-car-t-cell-therapy-in-children-and-young-adults-with/)
- [CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR](https://scholariq.org/papers/cd19-22-car-t-cells-in-children-and-young-adults-with-b-all-phase-1-results-and/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research-2/)

## Researcher university

- [Parker Institute for Cancer Immunotherapy](https://scholariq.org/institutions/parker-institute-for-cancer-immunotherapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.